Antidepressant Shows Early Promise for Mild COVID-19 ...Middle East

Medscape - News
The antidepressant fluvoxamine may help prevent serious respiratory problems when administered early in the course of COVID-19, results of a randomized, placebo-controlled trial show. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Antidepressant Shows Early Promise for Mild COVID-19 )

Apple Storegoogle play

Also on site :

Most viewed in News
NC news line - before 10 hours & 10 minute


Latest News